Clinical Trials on GVHD
Total 166 results
-
H. Lee Moffitt Cancer Center and Research InstituteNational Heart, Lung, and Blood Institute (NHLBI); CTI BioPharmaCompletedGVHD | Graft Vs Host DiseaseUnited States
-
Peking University People's HospitalCompletedLeukemia, GVHD, ATG, TransplantationChina
-
Massachusetts General HospitalSeagen Inc.TerminatedGVHD | Graft-vs-Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedGraft Versus Host Disease | GVHDUnited States
-
Shanghai Jiao Tong University School of MedicineShanghai Clinical Research CenterNot yet recruiting
-
NYU Langone HealthCompleted
-
VectivBio AGActive, not recruiting
-
University of SalamancaHaematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo...UnknownGraft-vs-Host Disease (GVHD)Spain
-
Massachusetts General HospitalNovartisTerminatedGraft Versus Host DiseaseUnited States
-
Massachusetts Eye and Ear InfirmaryCompletedSafety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host DiseaseOcular GVHDUnited States
-
Hadassah Medical OrganizationCompleted
-
AbGenomics B.V Taiwan BranchWithdrawnSteroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell TransplantationUnited States
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
Karolinska University HospitalCompletedAML | ALL | Acute GVHD | Tumor ImmunitySweden
-
CSL BehringNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingGraft Versus Host Disease (GVHD)United States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft Versus Host Disease | GVHDUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Dimitrios Tzachanis, MD PhDBristol-Myers SquibbActive, not recruitingHematologic Neoplasms | GVHDUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease (GVHD)United States
-
Shanghai Children's Medical CenterBioMérieuxUnknownGVHD - Graft-Versus-Host Disease
-
Shanghai Children's Medical CenterUnknownFecal Microbiota Transplantation for Treatment of Refractory Graft Versus Host Disease-a Pilot StudyFecal Microbiota Transplantation in GVHD
-
M.D. Anderson Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
Lophius Biosciences GmbHGerman Federal Ministry of Education and ResearchCompletedClinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients (AlloProtectCMV)Cytomegalovirus Infection | GVHDGermany
-
Henry Ford Health SystemRecruiting
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedHematologic MalignancyUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
The Korean Society of Hematopoietic Stem Cell TransplantationHoffmann-La RocheUnknownSteroid-Refractory Chronic GVHDKorea, Republic of
-
Peking University People's HospitalNot yet recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingImmune Mediated Anemia | Immune Mediated Thrombocytopenia | Chronic GVHDUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
University of PisaUnknownNeutropenic Enterocolitis | Intestinal GVHDItaly
-
Children's Hospital Medical Center, CincinnatiTerminatedGraft Versus Host Disease (GVHD) | Diagnoses That Require Stem Cell TransplantUnited States
-
Kalytera Therapeutics Israel, Ltd.Active, not recruitingPrevention aGVHDAustralia, Israel
-
Memorial Sloan Kettering Cancer CenterRecruitingGraft-Versus-Host Disease | GVHD | UndefinedUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationImmune Mediated Anemia | Immune Mediated Thrombocytopenia | Chronic GVHDUnited States
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
Indiana UniversityRecruitingOcular GVHDUnited States
-
Washington University School of MedicineRecruitingChronic GVHD | Acute Graft-versus-host Disease | Chronic Graft-versus-host Disease | Acute GVHDUnited States
-
Dana-Farber Cancer InstituteCompletedHematopoietic Stem Cell Transplantation (HSCT) | Acute GVH DiseaseUnited States
-
Chinese PLA General HospitalCompletedStem Cell Transplant Complications | aGVHDChina
-
MaaT PharmaRecruitingAcute Graft Versus Host Disease in Intestine | Steroid Refractory GVHDSpain, France, Germany, Austria, Belgium, Italy
-
Chinese PLA General HospitalThe Second Hospital of Hebei Medical University; Air Force Military Medical... and other collaboratorsCompleted
-
ReAlta Life Sciences, Inc.Not yet recruiting